155. Acquired aphasia with convulsive disorder Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drugs : 2 - (DrugBank : 2) / Drug target genes : 29 - Drug target pathways : 14
Acquired aphasia with convulsive disorder and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
155 | Acquired aphasia with convulsive disorder |
13 | Multiple sclerosis/Neuromyelitis optica |
152 | PCDH19 related syndrome |
201 | Angelman syndrome |
140 | Dorabe syndrome |
144 | Lennox-Gastaut syndrome |
193 | Prader-Willi syndrome |
205 | Fragile X syndrome related disease |
272 | Fibrodysplasia ossificans progressiva |
145 | West syndrome |
115 | Hereditary periodic paralysis |
154 | Epilepsy with continuous spikes and waves during slow sleep |
22 | Moyamoya disease |
156 | Rett syndrome |
231 | Alpha-1-antitrypsin deficiency |
158 | Tuberous sclerosis |
97 | Ulcerative colitis |
6 | Parkinson disease |
98 | Eosinophilic gastrointestinal disease |
296 | Biliary atresia |
18 | Spinocerebellar degeneration |
21 | Mitochondrial disease |
36 | Epidermolysis bullosa |
114 | Non-dystrophic myotonia syndrome |
230 | Alveolar hypoventilation syndrome |
298 | Hereditary pancreatitis |
3 | Spinal muscular atrophy |
206 | Fragile X syndrome |
17 | Multiple system atrophy |
75 | Cushing disease |
5 | Progressive supranuclear palsy |
70 | Spinal stenosis |
84 | Sarcoidosis |
8 | Huntington disease |
34 | Neurofibromatosis |
96 | Crohn disease |
2 | Amyotrophic lateral sclerosis |
46 | Malignant rheumatoid arthritis |
225 | Congenital nephrogenic diabetes insipidus |
90 | Retinitis pigmentosa |
86 | Pulmonary arterial hypertension |